The effects of G protein-coupled receptor 30 (GPR30) on cardiac glucose metabolism in diabetic ovariectomized female rats.

Mohammad ShahbazianFaezeh JafarynezhadMaryam YadeghariZeinab FarhadiSanaz Lotfi SamaniMansour EsmailidehajFatemeh SafariHossein Azizian

Published in: Journal of basic and clinical physiology and pharmacology (2022)

In conclusion, our work demonstrates that G-1 as a selective GPR30 agonist is a viable therapeutic approach against T2D and cardiometabolic diseases in multiple preclinical female models.

Keyphrases

fatty acid
type diabetes
left ventricular
wound healing
cell therapy
bone loss
heart failure
mesenchymal stem cells
bone marrow
atrial fibrillation